Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study

被引：0
作者：
Ziad A. Massy
Epiphane Kolla
Jean Ferrières
Eric Bruckert
Oriane Lambert
Nicolas Mansencal
Maurice Laville
Luc Frimat
Denis Fouque
Christian Combe
Roberto Pecoits-Filho
Bénédicte Stengel
Sophie Liabeuf
机构：
[1] Centre for Research in Epidemiology and Population Health (CESP),Department of Nephrology
[2] Inserm UMRS 1018,Department of Cardiology
[3] Team 5,Department of Epidemiology and Public Health, UMR INSERM 1027
[4] University Versailles-Saint Quentin,Service d’Endocrinologie Métabolisme et Prévention Cardiovasculaire
[5] Univ Paris-Saclay,Department of Cardiology
[6] CHU Ambroise Paré,Nephrology Department
[7] APHP,Nephrology Department
[8] Toulouse Rangueil University Hospital (CHU),Service de Néphrologie Transplantation Dialyse Aphérèse
[9] INSERM-Université de Toulouse,DOPPS Program Area
[10] Unité Fonctionnelle d’Aphérèse,School of Medicine
[11] Institut E3M et IHU Cardiométabolique,Pharmacology Department
[12] Hôpital Pitié Salpêtrière,MP3CV Laboratory, EA7517
[13] CHU Ambroise Paré,Division of Nephrology
[14] APHP,undefined
[15] AURAL,undefined
[16] CHRU de Nancy,undefined
[17] Lorraine University,undefined
[18] APEMAC,undefined
[19] Centre Hospitalier Lyon Sud,undefined
[20] Université de Lyon,undefined
[21] Carmen,undefined
[22] Centre Hospitalier Universitaire de Bordeaux,undefined
[23] INSERM,undefined
[24] U1026,undefined
[25] Univ Bordeaux,undefined
[26] Arbor Research Collaborative for Health,undefined
[27] Pontificia Universidade Catolica do Parana,undefined
[28] Paris-Sud,undefined
[29] Univ Paris-Saclay,undefined
[30] Amiens University Hospital,undefined
[31] University of Picardie Jules Verne,undefined
[32] Ambroise Paré Hospital,undefined
来源：
Journal of Nephrology | 2021年 / 34卷
关键词：
Chronic kidney disease; Cardiovascular disease; Lipid-lowering drugs; Lipids; Low-density lipoprotein cholesterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1467 / 1477
页数：10
相关论文
共 386 条
  • [1] Piepoli MF(2016)2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 37 2315-2381
  • [2] Hoes AW(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-2081
  • [3] Agewall S(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305
  • [4] Albus C(2012)Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 380 807-814
  • [5] Brotons C(2016)Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease J Clin Transl Endocrinol 6 8-14
  • [6] Catapano AL(2018)Lipid management in patients with chronic kidney disease Nat Rev Nephrol 14 727-749
  • [7] Cooney MT(2009)Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 1395-1407
  • [8] Corra U(2005)Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 238-248
  • [9] Cosyns B(2011)The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2181-2192
  • [10] Deaton C(2013)Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—a meta-analysis of 11 randomized controlled trials involving 21,295 participants Pharmacol Res 72 35-44
12345678910